Vesugen

Description

Vesugen is a short synthetic peptide reagent stocked for laboratories and qualified buyers sourcing research peptides in Canada. It arrives as a lyophilized powder in a sealed 20 mg vial, ready for reconstitution in a solvent appropriate to your protocol, and it sits in our anti-aging and cellular research category alongside other short-chain peptide bioregulators. It is a laboratory material, not a therapeutic product, and it is not intended for ingestion or administration to humans or animals.

Overview

Each unit is a single 20 mg vial of lyophilized Vesugen, also available in a box of ten for labs running repeat or parallel work. Lyophilization is the standard format for short peptides because it keeps the material stable in transit and lets the researcher control final concentration at the bench rather than accepting a fixed one. Before release, every batch goes to Janoshik, an independent analytical laboratory, for reversed-phase HPLC purity and mass spectrometry identity confirmation — testing that is separate from the manufacturer, so the numbers on the certificate are not self-reported. The certificate of analysis is matched to the batch you receive, not to a representative lot. Orders are kept cold and ship from within Canada with tracking, in discreet outer packaging.

What it is known for

Vesugen is known among researchers as one of the short peptide bioregulators — the compact Khavinson-type sequences frequently cited in vascular and cellular ageing literature — and it is usually bought as part of a comparative panel rather than in isolation. What determines the supplier, in practice, is whether the analytics are independent. Buyers choose this listing because purity and identity are verified by a third-party lab and the resulting certificate is tied to the specific batch shipped, which is what allows a result to be defended or repeated later.

Key features

• Third-party HPLC purity testing by Janoshik — Purity is confirmed by a lab with no stake in the sale, so you are not relying on a manufacturer’s own paperwork when you record reagent quality in your methods.
• Mass spectrometry identity confirmation — Verifies the material is the peptide it is labelled as, before it enters an assay — the failure mode that costs the most time when it goes unnoticed.
• Batch-matched certificate of analysis — The document corresponds to the vial in your hand, so results stay traceable to a specific lot months after the work is done.
• Lyophilized powder format — More stable for shipping and storage than a pre-made solution, and it lets you set solvent and concentration to suit your own protocol.
• 20 mg single vial or box of ten — Run a pilot on one vial, then scale to a full series without changing supplier or lot handling — useful when consistency across replicates matters.
• Cold storage and tracked domestic shipping — Material stays under temperature control until it leaves, and ships within Canada, avoiding customs delays and the temperature exposure that comes with them.
• Discreet outer packaging — Nothing on the exterior identifies the contents, which suits shared receiving areas and institutional mailrooms.

Benefits

• Independent analytics mean unexpected results can be attributed to the experiment rather than the reagent.
• Documentation is ready for lab records, grant reporting and internal QA without a separate request.
• Domestic dispatch shortens transit and keeps the cold chain simple.
• Single-vial and ten-vial options let you match spend to the stage of the project.
• A consistent, verified starting material makes replicate and follow-up work more comparable.

Specifications

Typical applications

• In-vitro cellular and anti-ageing research models
• Comparative studies across short-chain peptide bioregulators
• Analytical method development and reference work
• Preliminary screening before committing to a larger reagent order

Important information

• Research use only. Not a drug, supplement, food or cosmetic; not for human or veterinary use, ingestion or administration.
• Keep vials cold on arrival and store as your laboratory’s protocol for lyophilized peptides requires.
• Reconstitute in a solvent suited to your assay; the powder is supplied unreconstituted so that choice remains yours.
• Confirm you have received the certificate of analysis matching your batch, and file it with your experimental records.
• Handle with standard laboratory PPE and dispose of material according to your institution’s procedures.

Common questions

What exactly is supplied?

A sealed vial containing 20 mg of Vesugen as a lyophilized powder, either singly or in a box of ten. No solvent, syringes or reconstitution supplies are included.

Who does the testing?

Janoshik, an independent analytical laboratory. They run reversed-phase HPLC for purity and mass spectrometry for identity. Because they are separate from the manufacturer, the results are not self-certified.

Is the certificate specific to my batch?

Yes. The COA is matched to the batch shipped rather than being a generic or representative document, so your records stay traceable to the actual lot.

How should I store it after it arrives?

Keep the vial cold and sealed until use, following your laboratory’s standard handling for lyophilized peptides. Once reconstituted, storage is determined by your solvent and protocol.

Where does it ship from, and how is it packaged?

From within Canada, with nationwide tracking. Outer packaging is discreet and does not identify the contents.

Can this be used in humans or animals?

No. It is sold strictly for in-vitro laboratory research. It is not a drug, supplement, food or cosmetic, and it is not intended to diagnose, treat, cure or prevent any disease.

In summary

A 20 mg lyophilized vial of Vesugen with independent HPLC and MS results behind it, a certificate tied to your batch, and cold, tracked dispatch from Canada. Available singly for pilot work or in a box of ten for extended studies — strictly for in-vitro laboratory research.